Abbott Laboratories Revenue per Employee (ABT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Abbott Laboratories  (NYSE: ABT)
 

Abbott Laboratories's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 14.46% in the third quarter 2026, year on year to cumulative value of $48,229 million, Abbott Laboratories's revenue per employee grew on a trailing twelve months basis to $ 419,383. The productivity of Abbott Laboratories's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 245 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 2034, from total ranking in previous quarter at 2372. Abbott Laboratories has 115,000 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABT Revenue per Employee (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Revenue Change 14.46 % 13.02 % 7.78 % 4.42 % 6.9 %
Sales per Employee (TTM) $ 419,383 405,087 392,470 385,461 381,243
ABT's Total Ranking # 2034 # 2372 # 2068 # 2074 # 2105
Seq. Revenue Change 3.34 % 12.8 % -2.57 % 0.79 % 2.04 %

ABT Company Profile >> Back to ABT Efficiency Comparisons >> Compare ABT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 124
Healthcare Sector # 246
Overall Market # 2034

Revenue per Employee Statistics
High Average Low
$ 405,087 $ 268,276 $ 170,304
(Jun 30 2026)   (March 31, 2014)



Financial Statements
Abbott Laboratories's Revenue MRQ $ 13,013 Millions Visit ABT's Income Statement
Abbott Laboratories's Revenues TTM $ 48,229 Millions Visit ABT's aggregate revenue growth
What are ABT's Sales? Visit ABT's Sales by Segment




Other Ratios
Abbott Laboratories's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ABT's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ABT's Competitors
Revenue per Employee for ABT's Suppliers
Revenue per Employee for ABT's Customers

You may also want to know
ABT's Sales Growth Rates ABT's Pe Price to earnings ratio ABT's Receivables Turnover Ratio ABT's Stock Quote
ABT's Net Income Growth Rates ABT's Ps Price to Sales ratio ABT's Sales per Employee ABT's Asset Turnover Ratio
ABT's Net Margin ABT's Pb Price to Book ratio ABT's Financial Strength Ratios ABT's Dividend Payout Ratio
Date modified: 2026-11-05T14:27:26+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2026Number of Employees Sep 30 2026
Emergent Biosolutions Inc   721,222.22 $ 649.100  Million 900 
Intuitive Surgical Inc   711,803.07 $ 12,115.600  Million 17,021 
Johnson and Johnson  705,504.26 $ 99,335.000  Million 140,800 
Rhythm Pharmaceuticals Inc   678,135.27 $ 280.748  Million 414 
Inspire Medical Systems inc   661,810.95 $ 882.194  Million 1,333 
Caredx Inc   650,190.85 $ 497.396  Million 765 
Organon and Co   611,100.00 $ 6,111.000  Million 10,000 
Bioventus Inc   609,707.29 $ 585.319  Million 960 
Si bone inc   590,928.19 $ 222.189  Million 376 
Butterfly Network Inc   562,340.91 $ 123.715  Million 220 
Henry Schein Inc   549,360.00 $ 13,734.000  Million 25,000 
Bausch Health Companies Inc   547,438.42 $ 11,113.000  Million 20,300 
Iradimed Corporation  538,192.16 $ 89.340  Million 166 
Glaukos Corp  528,660.88 $ 578.355  Million 1,094 
Angiodynamics Inc   512,316.46 $ 323.784  Million 632 
Resmed Inc   505,115.57 $ 5,743.164  Million 11,370 
Avantor Inc   491,525.93 $ 6,635.600  Million 13,500 
Stryker Corp  469,642.86 $ 26,300.000  Million 56,000 
Dexcom Inc   459,900.90 $ 5,104.900  Million 11,100 
Medpace Holdings Inc   457,804.03 $ 2,838.385  Million 6,200 
Novocure Limited  451,955.14 $ 725.388  Million 1,605 
Omniab Inc   451,808.99 $ 40.211  Million 89 
Teladoc Health Inc   440,739.82 $ 2,468.143  Million 5,600 
Orthopediatrics Corp  437,981.73 $ 263.665  Million 602 
Vanda Pharmaceuticals Inc   430,165.10 $ 229.278  Million 533 
Axogen inc   429,141.48 $ 266.926  Million 622 
Idexx Laboratories Inc  423,970.45 $ 4,663.675  Million 11,000 
3m Company  417,305.79 $ 25,247.000  Million 60,500 
Bausch and Lomb Corp  416,769.23 $ 5,418.000  Million 13,000 
Teva Pharmaceutical Industries Limited  412,960.24 $ 14,020.000  Million 33,950 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.